Thrombocytosis: Diagnostic Evaluation, Thrombotic Risk Stratification, and Risk-Based Management Strategies
Thrombosis · 08.06.2011 · 2011 · 1-16
DOI: 10.1155/2011/536062 ↗Kurz gefasst
Fachartikel in der Zeitschrift Thrombosis, erschienen am 08.06.2011. Verfasst von Jonathan S Bleeker und 1 weiteren Autor:innen. Beteiligte Einrichtung: Division of Hematology, Department of Medicine, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA. Die Arbeit wurde bisher 116-mal zitiert (Crossref) und nennt 168 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 3.0).
Abstract (Originalsprache)
Thrombocytosis is a commonly encountered clinical scenario, with a large proportion of cases discovered incidentally. The differential diagnosis for thrombocytosis is broad and the diagnostic process can be challenging. Thrombocytosis can be spurious, attributed to a reactive process or due to clonal disorder. This distinction is important as it carries implications for evaluation, prognosis, and treatment. Clonal thrombocytosis associated with the myeloproliferative neoplasms, especially essential thrombocythemia and polycythemia vera, carries a unique prognostic profile, with a markedly increased risk of thrombosis. This risk is the driving factor behind treatment strategies in these disorders. Clinical trials utilizing targeted therapies in thrombocytosis are ongoing with new therapeutic targets waiting to be explored. This paper will outline the mechanisms underlying thrombocytosis, the diagnostic evaluation of thrombocytosis, complications of thrombocytosis with a special focus on thrombotic risk as well as treatment options for clonal processes leading to thrombocytosis, including essential thrombocythemia and polycythemia vera.
Autor:innen und Institutionen
- Division of Hematology, Department of Medicine, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA.
Zitieren
APA
Bleeker, J. S., & Hogan, W. J. (2011). Thrombocytosis: Diagnostic Evaluation, Thrombotic Risk Stratification, and Risk-Based Management Strategies. Thrombosis, 2011, 1-16. https://doi.org/10.1155/2011/536062
Vancouver
Bleeker JS, Hogan WJ. Thrombocytosis: Diagnostic Evaluation, Thrombotic Risk Stratification, and Risk-Based Management Strategies. Thrombosis. 2011;2011:1-16. doi:10.1155/2011/536062
BibTeX
@article{Bleeker2011,
author = {Bleeker, Jonathan S and Hogan, William J},
title = {Thrombocytosis: Diagnostic Evaluation, Thrombotic Risk Stratification, and Risk-Based Management Strategies},
journal = {Thrombosis},
year = {2011},
volume = {2011},
pages = {1--16},
doi = {10.1155/2011/536062}
}
EUVIMED